In terms of cancer, 90 percent of cancer that attacks specifically there are several types, including cervical cancer, prostate cancer, breast cancer and others. Looks indeed women are more likely to develop cervical cancer and breast cancer. However, when viewed in terms of habit, rather than cervical cancer, breast cancer caused by excessive which expression or human epidermal growth factor receptor-2, or often abbreviated as HER2 tend to be more violent, more quickly spread to parts of the body, and even more resistant to drugs. It is made in developing countries such as Indonesia to make this type of cancer as a serious threat of all cases are associated with breast cancer.
The breast cancer patients with HER2 status affected positively experiencing symptoms that tend to be slightly different. They have excess protein or over-expression of a potential cause of cancer. Breast cancer cell types positive HER2 is likely to be immune to drugs, radiotherapy and even chemotherapy. This is due to an abnormality in the form of excess protein causes cancer causes the cancer cells have super characteristics, such as more severe and progressive. Just like a super-human who has a malignant force, that can be illustrated on the HER2 cancer types.
Based on the data obtained from the research world health organization (WHO) found, there are as many as 60 percent of breast cancer cases in developing countries, and nearly half of the patients were infected experience the more severe that died. Four decades ago, not so much emerge breast cancer, but the cancer occurrence seems to be the beginning of health disasters that can destroy human life.
In general, the number of deaths caused by cancer is not going to the doctor or the inability of drugs to cure cancer, but late treatment more toward prevention in the healing process. Why do I say so? most cancer patients realized that he was stricken with cancer when the physical body is in a state of 75 percent of esophageal cancer. This is evident when the hospital refer cancer patients to the hospital in a state of advanced stage. It creates opportunities cure for cancer be smaller than before the advanced stage. Because so often a new cancer patients come when the state of advanced stage, it performed a variety of counseling as recognize your body to prevent cancer and conducted a variety of research on new therapies, and one of them is as follows.
Research on cases of HER2-positive breast cancer types managed to find trastuzumab, a monoclonal antibody designed to target or inhibit the function of HER2. In addition to inhibiting the function of HER2, trastuzumab is also able to stimulate the immune system to destroy cancer cells. This drug is the first monoclonal antibody used to treat breast cancers. Therapeutic treatment with trastuzumab could potentially extend the life of HER2-positive breast cancer patients. This drug is a special anti-HER2 medicine suitable for the treatment of cancer that occurs in the long term.
Is usually the treatment in hospital, the drug included in two ways, namely by mouth with a drink and through the blood by means of an injection or intravenously through the blood vessels. The method of treatment through infusion had an effect less comfortable for the patient. I just personally when hospitalized for more than 23 days is not very convenient because the IV needle should move as much as 5 times from right hand to left hand only the injection was different. Additionally, this infusion method turned out to have an influence on cardiac dysfunction due directly correlates with the pulse of blood vessels.
On the other hand, treatment with trastuzumab for patients tend to be more comfortable and safe. This factor is important because the treatment of breast cancer requires a long time, at least 1 year. Unlike chemotherapy, trastuzumab therapy of breast cancer with no side effects like hair loss, bone marrow suppression, ulcers and vomiting. The use of trastuzumab with chemotherapy combinations have been tested clinically in various parts of the world.
No comments:
Post a Comment